These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29422651)

  • 1. Impact of erroneous meal insulin bolus with dual-hormone artificial pancreas using a simplified bolus strategy - A randomized controlled trial.
    Gingras V; Smaoui MR; Cameli C; Messier V; Ladouceur M; Legault L; Rabasa-Lhoret R
    Sci Rep; 2018 Feb; 8(1):2621. PubMed ID: 29422651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Simplified Semiquantitative Meal Bolus Strategy Combined with Single- and Dual-Hormone Closed-Loop Delivery in Patients with Type 1 Diabetes: A Pilot Study.
    Gingras V; Haidar A; Messier V; Legault L; Ladouceur M; Rabasa-Lhoret R
    Diabetes Technol Ther; 2016 Aug; 18(8):464-71. PubMed ID: 27191385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial.
    Haidar A; Legault L; Dallaire M; Alkhateeb A; Coriati A; Messier V; Cheng P; Millette M; Boulet B; Rabasa-Lhoret R
    CMAJ; 2013 Mar; 185(4):297-305. PubMed ID: 23359039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual-Hormone Closed-Loop System Using a Liquid Stable Glucagon Formulation Versus Insulin-Only Closed-Loop System Compared With a Predictive Low Glucose Suspend System: An Open-Label, Outpatient, Single-Center, Crossover, Randomized Controlled Trial.
    Wilson LM; Jacobs PG; Ramsey KL; Resalat N; Reddy R; Branigan D; Leitschuh J; Gabo V; Guillot F; Senf B; El Youssef J; Steineck IIK; Tyler NS; Castle JR
    Diabetes Care; 2020 Nov; 43(11):2721-2729. PubMed ID: 32907828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.
    Elleri D; Biagioni M; Allen JM; Kumareswaran K; Leelarathna L; Caldwell K; Nodale M; Wilinska ME; Haidar A; Calhoun P; Kollman C; Jackson NC; Umpleby AM; Acerini CL; Dunger DB; Hovorka R
    Diabetes Obes Metab; 2015 Dec; 17(12):1173-9. PubMed ID: 26257323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing automatic closed-loop glucose control in type 1 diabetes with an adaptive meal bolus calculator - in silico evaluation under intra-day variability.
    Herrero P; Bondia J; Adewuyi O; Pesl P; El-Sharkawy M; Reddy M; Toumazou C; Oliver N; Georgiou P
    Comput Methods Programs Biomed; 2017 Jul; 146():125-131. PubMed ID: 28688482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.
    Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R
    Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The challenges of achieving postprandial glucose control using closed-loop systems in patients with type 1 diabetes.
    Gingras V; Taleb N; Roy-Fleming A; Legault L; Rabasa-Lhoret R
    Diabetes Obes Metab; 2018 Feb; 20(2):245-256. PubMed ID: 28675686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of the Omnipod Personalized Model Predictive Control Algorithm with Meal Bolus Challenges in Adults with Type 1 Diabetes.
    Buckingham BA; Christiansen MP; Forlenza GP; Wadwa RP; Peyser TA; Lee JB; O'Connor J; Dassau E; Huyett LM; Layne JE; Ly TT
    Diabetes Technol Ther; 2018 Sep; 20(9):585-595. PubMed ID: 30070928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized Outpatient Trial of Single- and Dual-Hormone Closed-Loop Systems That Adapt to Exercise Using Wearable Sensors.
    Castle JR; El Youssef J; Wilson LM; Reddy R; Resalat N; Branigan D; Ramsey K; Leitschuh J; Rajhbeharrysingh U; Senf B; Sugerman SM; Gabo V; Jacobs PG
    Diabetes Care; 2018 Jul; 41(7):1471-1477. PubMed ID: 29752345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A fully artificial pancreas versus a hybrid artificial pancreas for type 1 diabetes: a single-centre, open-label, randomised controlled, crossover, non-inferiority trial.
    Tsoukas MA; Majdpour D; Yale JF; Fathi AE; Garfield N; Rutkowski J; Rene J; Legault L; Haidar A
    Lancet Digit Health; 2021 Nov; 3(11):e723-e732. PubMed ID: 34580055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter closed-loop/hybrid meal bolus insulin delivery with type 1 diabetes.
    Chase HP; Doyle FJ; Zisser H; Renard E; Nimri R; Cobelli C; Buckingham BA; Maahs DM; Anderson S; Magni L; Lum J; Calhoun P; Kollman C; Beck RW;
    Diabetes Technol Ther; 2014 Oct; 16(10):623-32. PubMed ID: 25188375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automatic Detection and Estimation of Unannounced Meals for Multivariable Artificial Pancreas System.
    Samadi S; Rashid M; Turksoy K; Feng J; Hajizadeh I; Hobbs N; Lazaro C; Sevil M; Littlejohn E; Cinar A
    Diabetes Technol Ther; 2018 Mar; 20(3):235-246. PubMed ID: 29406789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The additional dose of insulin for high-protein mixed meal provides better glycemic control in children with type 1 diabetes on insulin pumps: randomized cross-over study.
    Piechowiak K; Dżygało K; Szypowska A
    Pediatr Diabetes; 2017 Dec; 18(8):861-868. PubMed ID: 28117542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overnight Glucose Control with Dual- and Single-Hormone Artificial Pancreas in Type 1 Diabetes with Hypoglycemia Unawareness: A Randomized Controlled Trial.
    Abitbol A; Rabasa-Lhoret R; Messier V; Legault L; Smaoui M; Cohen N; Haidar A
    Diabetes Technol Ther; 2018 Mar; 20(3):189-196. PubMed ID: 29393675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of automatic bolus calculator with automatic speech recognition in patients with type 1 diabetes: A randomized cross-over trial.
    Foltynski P; Ladyzynski P; Pankowska E; Mazurczak K
    J Diabetes; 2018 Jul; 10(7):600-608. PubMed ID: 29316338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of closed-loop therapy during reduction or omission of meal boluses in adolescents with type 1 diabetes: a randomized clinical trial.
    Elleri D; Maltoni G; Allen JM; Nodale M; Kumareswaran K; Leelarathna L; Thabit H; Caldwell K; Wilinska ME; Calhoun P; Kollman C; Dunger DB; Hovorka R
    Diabetes Obes Metab; 2014 Nov; 16(11):1174-8. PubMed ID: 24909206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Closed-Loop Control of Postprandial Glycemia Using an Insulin-on-Board Limitation Through Continuous Action on Glucose Target.
    Rossetti P; Quirós C; Moscardó V; Comas A; Giménez M; Ampudia-Blasco FJ; León F; Montaser E; Conget I; Bondia J; Vehí J
    Diabetes Technol Ther; 2017 Jun; 19(6):355-362. PubMed ID: 28459603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outpatient 60-hour day-and-night glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or sensor-augmented pump therapy in adults with type 1 diabetes: An open-label, randomised, crossover, controlled trial.
    Haidar A; Messier V; Legault L; Ladouceur M; Rabasa-Lhoret R
    Diabetes Obes Metab; 2017 May; 19(5):713-720. PubMed ID: 28094472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Use of a Smart Bolus Calculator Informed by Real-time Insulin Sensitivity Assessments Reduces Postprandial Hypoglycemia Following an Aerobic Exercise Session in Individuals With Type 1 Diabetes.
    Fabris C; Nass RM; Pinnata J; Carr KA; Koravi CLK; Barnett CL; Oliveri MC; Anderson SM; Chernavvsky DR; Breton MD
    Diabetes Care; 2020 Apr; 43(4):799-805. PubMed ID: 32144167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.